Scrip
Market Insight - How the IMI is reinvigorating European pharma research
19 January 2010
Dr David Pountney, Colin Maher and Nick Beckett
Please Login to read the full article.
19 January 2010
Dr David Pountney, Colin Maher and Nick Beckett
The Innovative Medicines Initiative (IMI) is a public-private partnership which aims to bolster Europe's competitive edge in pharmaceutical research and improve the mechanisms for bringing new medicines to the marketplace.
Dr David Pountney
,
Colin Maher
and
Nick...
Please Login to read the full article.
RELATED CONTENT
NEWS
- EU's innovative medicines initiative homes in on efficacy and knowledge management
- Spanish pharma industry calls for new public-private partnership model to drive growth
- Evotec to acquire DeveloGen for €14 million plus milestones
- Experts find flaws in proposed Indian "Bayh-Dole" legislation
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
